MNDL Bio
Optimization of Gene Expression using Computational Approaches
StartupMNDL Bio is a Herzliya-based startup in the Health Tech & Life Sciences sector, established in 2023. Optimization of Gene Expression using Computational Approaches. The company has raised a total of $2.1M across 2 funding rounds, currently at the Pre-Seed stage. MNDL Bio was founded by Steve Grun, Eran Miller, Tamir Tuller. Key investors include Earth & Beyond Ventures, CPT Capital. The company has 1-10 employees. Core technologies: Biologicals, Genes.
With $2.1M in total funding, MNDL Bio is a Pre-Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Alpha. The company holds 1 patent. MNDL Bio is identified as relevant to climate technology.
- StagePre-Seed
- ProductAlpha
- ModelB2B
- Employees1-10
- HQHerzliya
- DistrictCenter District
- Last Round$2M
- Earth & Beyond VenturesLead
- CPT Capital
Steve GrunCo-founder & CEO
Eran MillerCo-founder & CBO
Tamir TullerCo-founder & CSO
4 articles covered by sources including www.timesofisrael.com,
www.jpost.com,
www.calcalistech.com.
What does MNDL Bio do?
MNDL Bio's solution focuses on optimizing gene expression in cells to significantly increase protein production yield. Leveraging cutting-edge technology, including advanced algorithms and patented methods, the core technology utilizes Artificial Intelligence (AI) and Machine Learning (ML) based on genomic Big Data. MNDL enhances the efficiency of biological systems, making them more productive and cost-effective. This has far-reaching applications across various sectors. The company won the "Coller Startup Competition" for Edition 2023.
How much funding has MNDL Bio raised?
MNDL Bio has raised $2.1M in total funding across 2 rounds. The company is currently at the Pre-Seed stage. Key investors include Earth & Beyond Ventures, CPT Capital.
Who founded MNDL Bio?
MNDL Bio was founded in 2023 by Steve Grun (Co-founder & CEO), Eran Miller (Co-founder & CBO), Tamir Tuller (Co-founder & CSO).
What sector is MNDL Bio in?
MNDL Bio operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Biomaterials & Tissue Engineering, Climate Tech, Clean Industry Tech , Sustainable Materials & Circularity, with core technologies in Biologicals, Genes. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, Industrial Manufacturing, Process Industries, Plastics, Chemicals & Petrochemicals, Energy, Utilities & Waste Management, New Fuels, Biofuels, Waste Treatment, Environmental Services & Recycling, Agriculture & Food, Livestock.
Where is MNDL Bio located?
MNDL Bio is based in Herzliya, Israel, Center District.